# Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF

> **NCT02690064** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Augusta University** · enrollment: 13 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** Acute Antioxidant
- **DIETARY_SUPPLEMENT:** Chronic Antioxidant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02690064
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02690064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02690064, "Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02690064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*